BOSTON (MedPage Today) -- In patients with advanced liver disease related to hepatitis C, a course of pegylated interferon and ribavirin (Rebetol) before liver transplant may help them avoid recurrence of infection, a researcher said here.
AASLD: Treating Before Transplant Cuts HCV Recurrence (CME/CE)Courtesy MedPage Today Surgery Fri, 11/06/2009 - 08:34
BOSTON (MedPage Today) -- In patients with advanced liver disease related to hepatitis C, a course of pegylated interferon and ribavirin (Rebetol) before liver transplant may help them avoid recurrence of infection, a researcher said here. Popular products More related itemsHIV No Barrier to Liver Transplant
AASLD: High SVR Rates Seen with Telaprevir for...
AASLD: Direct Antivirals Can Beat HCV Without...
Pedifix Wart Stick Solid-stick Wart Remover Net...
Ride 'Em Cowgirl! Sex Position Secrets For Better...
|
Popular by tags WeekMonth |
Post new comment